BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31848379)

  • 1. Assessing the therapeutic potential of Graptopetalum paraguayense on Alzheimer's disease using patient iPSC-derived neurons.
    Wu PC; Fann MJ; Tran TT; Chen SC; Devina T; Cheng IH; Lien CC; Kao LS; Wang SJ; Fuh JL; Tzeng TT; Huang CY; Shiao YJ; Wong YH
    Sci Rep; 2019 Dec; 9(1):19301. PubMed ID: 31848379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Alzheimer's Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation.
    Chang KH; Lee-Chen GJ; Huang CC; Lin JL; Chen YJ; Wei PC; Lo YS; Yao CF; Kuo MW; Chen CM
    Mol Neurobiol; 2019 Jun; 56(6):3972-3983. PubMed ID: 30238389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons.
    Nieweg K; Andreyeva A; van Stegen B; Tanriöver G; Gottmann K
    Cell Death Dis; 2015 Apr; 6(4):e1709. PubMed ID: 25837485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons.
    Chang CY; Chen SM; Lu HE; Lai SM; Lai PS; Shen PW; Chen PY; Shen CI; Harn HJ; Lin SZ; Hwang SM; Su HL
    Sci Rep; 2015 Mar; 5():8744. PubMed ID: 25735452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease.
    Kondo T; Imamura K; Funayama M; Tsukita K; Miyake M; Ohta A; Woltjen K; Nakagawa M; Asada T; Arai T; Kawakatsu S; Izumi Y; Kaji R; Iwata N; Inoue H
    Cell Rep; 2017 Nov; 21(8):2304-2312. PubMed ID: 29166618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability.
    Muratore CR; Zhou C; Liao M; Fernandez MA; Taylor WM; Lagomarsino VN; Pearse RV; Rice HC; Negri JM; He A; Srikanth P; Callahan DG; Shin T; Zhou M; Bennett DA; Noggle S; Love JC; Selkoe DJ; Young-Pearse TL
    Stem Cell Reports; 2017 Dec; 9(6):1868-1884. PubMed ID: 29153990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
    Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
    Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening.
    Wang C; Ward ME; Chen R; Liu K; Tracy TE; Chen X; Xie M; Sohn PD; Ludwig C; Meyer-Franke A; Karch CM; Ding S; Gan L
    Stem Cell Reports; 2017 Oct; 9(4):1221-1233. PubMed ID: 28966121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
    Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
    BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C; Kulic L; Nitsch RM
    PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.
    Sahlgren Bendtsen KM; Hall VJ
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy.
    Cheng C; Reis SA; Adams ET; Fass DM; Angus SP; Stuhlmiller TJ; Richardson J; Olafson H; Wang ET; Patnaik D; Beauchamp RL; Feldman DA; Silva MC; Sur M; Johnson GL; Ramesh V; Miller BL; Temple S; Kosik KS; Dickerson BC; Haggarty SJ
    Sci Rep; 2021 Aug; 11(1):17029. PubMed ID: 34426604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity.
    Ando K; Maruko-Otake A; Ohtake Y; Hayashishita M; Sekiya M; Iijima KM
    PLoS Genet; 2016 Mar; 12(3):e1005917. PubMed ID: 27023670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yuan‑zhi‑san inhibits tau protein aggregation in an Aβ
    Li B; Xie PJ; Hao YW; Guo Y; Yu JR; Gong DY; Guo J; Zeng JH; Zhang Y
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells.
    Armijo E; Gonzalez C; Shahnawaz M; Flores A; Davis B; Soto C
    Neurosci Lett; 2017 Feb; 639():74-81. PubMed ID: 28034781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling amyloid beta and tau pathology in human cerebral organoids.
    Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C
    Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
    Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
    Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.